CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT); Amended Notice of Meeting, 22078 [2018-10111]

Download as PDF 22078 Federal Register / Vol. 83, No. 92 / Friday, May 11, 2018 / Notices [FR Doc. 2018–10111 Filed 5–10–18; 8:45 am] This notice announces that a public meeting of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) (‘‘Committee’’) will be held on Wednesday, July 25, 2018. This meeting will specifically focus on obtaining the MEDCAC’s appraisal and recommendations regarding the state of evidence for procedural volume requirements, especially pertaining to surgical aortic valve replacements (SAVRs), transcatheter aortic valve replacements (TAVRs) and percutaneous coronary interventions (PCIs), for hospitals to begin and maintain TAVR programs. This meeting is open to the public in accordance with the Federal Advisory Committee Act. DATES: Meeting Date: The public meeting will be held on Wednesday, July 25, 2018 from 7:30 a.m. until 4:30 p.m., Eastern Daylight Time (EDT). Deadline for Submission of Written Comments: Written comments must be received at the address specified in the ADDRESSES section of this notice by 5:00 p.m., EDT, Monday, June 18, 2018. Once submitted, all comments are final. Deadlines for Speaker Registration and Presentation Materials: The deadline to register to be a speaker and to submit PowerPoint presentation materials and writings that will be used in support of an oral presentation is 5:00 p.m., EDT on Monday, June 18, 2018. Speakers may register by phone or via email by contacting the person listed in the FOR FURTHER INFORMATION CONTACT section of this notice. Presentation materials must be received at the address specified in the ADDRESSES section of this notice. Deadline for All Other Attendees Registration: Individuals may register online at https://www.cms.gov/apps/ events/upcomingevents. asp?strOrderBy=1&type=3 or by phone by contacting the person listed in the BILLING CODE 4163–18–P FOR FURTHER INFORMATION CONTACT SUMMARY: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT); Amended Notice of Meeting Notice is hereby given of a change in the meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT); the meeting will be held on May 9, 2018, 8:30 a.m. to 5:00 p.m., EDT and May 10, 2018, 8:30 a.m. to 12:00 p.m., EDT. CDC Corporate Square, Building 8, Conference Room 1–ABC, 8 Corporate Boulevard, Atlanta, Georgia 30329 which was published in the Federal Register on April 2, 2018, Volume 83, Number 63, pages 13986– 13987. The meeting is being amended to add Adobe Connect meeting information https://adobeconnect.cdc.gov/chac/, phone number: 1 (877) 603–4228, participant passcode: 42598858. The meeting is open to the public. FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee Management Specialist, CDC, 1600 Clifton Road, NE, Mailstop: E–07, Atlanta, Georgia 30333, telephone (404) 639–8317; zkr7@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services sradovich on DSK3GMQ082PROD with NOTICES [CMS–3361–N] Medicare Program; Meeting of the Medicare Evidence Development and Coverage Advisory Committee—July 25, 2018 Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice of meeting. AGENCY: VerDate Sep<11>2014 19:21 May 10, 2018 Jkt 244001 section of this notice by 5:00 p.m. EDT, Wednesday, July 18, 2018. We will be broadcasting the meeting live via Webcast at https://www.cms.gov/ live/. Deadline for Submitting a Request for Special Accommodations: Persons attending the meeting who are hearing or visually impaired, or have a condition that requires special assistance or accommodations, are asked to contact the Executive Secretary as specified in the FOR FURTHER INFORMATION CONTACT section of this notice no later than 5:00 p.m., EDT Friday, July 6, 2018. ADDRESSES: PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 Meeting Location: The meeting will be held in the main auditorium of the Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Baltimore, MD 21244. Submission of Presentations and Comments: Presentation materials and written comments that will be presented at the meeting must be submitted via email to MedCACpresentations@ cms.hhs.gov or by regular mail to the contact listed in the FOR FURTHER INFORMATION CONTACT section of this notice by the date specified in the DATES section of this notice. FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for MEDCAC, Centers for Medicare & Medicaid Services, Center for Clinical Standards and Quality, Coverage and Analysis Group, S3–02–01, 7500 Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by phone (410–786–0309) or via email at Maria.Ellis@cms.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background MEDCAC, formerly known as the Medicare Coverage Advisory Committee (MCAC), is advisory in nature, with all final coverage decisions resting with CMS. MEDCAC is used to supplement CMS’ internal expertise. Accordingly, the advice rendered by the MEDCAC is most useful when it results from a process of full scientific inquiry and thoughtful discussion, in an open forum, with careful framing of recommendations and clear identification of the basis of those recommendations. MEDCAC members are valued for their background, education, and expertise in a wide variety of scientific, clinical, and other related fields. (For more information on MCAC, see the MEDCAC Charter (https:// www.cms.gov/Regulations-andGuidance/Guidance/FACA/Downloads/ medcaccharter.pdf) and the CMS Guidance Document, Factors CMS Considers in Referring Topics to the MEDCAC (https://www.cms.gov/ medicare-coverage-database/details/ medicare-coverage-documentdetails.aspx?MCDId=10)). II. Meeting Topic and Format This notice announces the Wednesday, July 25, 2018, public meeting of the Committee. During this meeting, the Committee will discuss their appraisal and recommendations regarding the state of evidence for procedural volume requirements, especially pertaining to SAVRs, TAVRs and PCIs, for hospitals to begin and maintain TAVR programs. Background E:\FR\FM\11MYN1.SGM 11MYN1

Agencies

[Federal Register Volume 83, Number 92 (Friday, May 11, 2018)]
[Notices]
[Page 22078]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10111]



[[Page 22078]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment (CHACHSPT); Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the CDC/HRSA 
Advisory Committee on HIV, Viral Hepatitis and STD Prevention and 
Treatment (CHACHSPT); the meeting will be held on May 9, 2018, 8:30 
a.m. to 5:00 p.m., EDT and May 10, 2018, 8:30 a.m. to 12:00 p.m., EDT. 
CDC Corporate Square, Building 8, Conference Room 1-ABC, 8 Corporate 
Boulevard, Atlanta, Georgia 30329 which was published in the Federal 
Register on April 2, 2018, Volume 83, Number 63, pages 13986-13987.
    The meeting is being amended to add Adobe Connect meeting 
information https://adobeconnect.cdc.gov/chac/, phone number: 1 (877) 
603-4228, participant passcode: 42598858.
    The meeting is open to the public.

FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee 
Management Specialist, CDC, 1600 Clifton Road, NE, Mailstop: E-07, 
Atlanta, Georgia 30333, telephone (404) 639-8317; [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2018-10111 Filed 5-10-18; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.